Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Jul 28, 2020 12:00 PM EDT
ARO-ENaC KOL Webinar
Aug 5, 2020 4:30 PM EDT
Arrowhead Pharmaceuticals 2020 Third Quarter Results
Archived Events
Date Event Details
Feb 27 - Mar 1, 2018 12:00 AM EST
AsiaTIDES: Oligonucleotide and Peptide Therapeutics
Kyoto, Japan
Feb 22, 2018 3:10 PM UTC
SMI RNA Therapeutics Conference
London
Feb 9, 2018 4:30 PM EST
Arrowhead Fiscal 2018 First Quarter Results
Jan 8 - Jan 10, 2018 12:00 AM EST
JP Morgan Healthcare Conference Week
Dec 12, 2017 4:30 PM EST
Arrowhead Pharmaceuticals 2017 Fiscal Year End Results
Dec 5, 2017 6:10 PM HST
HEP DART 2017
Kona, Hawaii
Nov 28, 2017 9:30 AM EST
29th Annual Piper Jaffray Healthcare Conference
Nov 13 - Nov 15, 2017 12:00 AM EST
BIT's 8th World Gene Convention-2017
Macau, China
Oct 23, 2017
The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Disease
Washington, DC

Subcutaneous delivery of a RNA interference (RNAi) therapeutic candidate for alpha-1 antitrypsin deficiency (AATD)-related liver disease produces deep and prolonged knockdown of plasma AAT

  • Publication Number: LB-21
  • Session: Late-Breaking Poster Session
  • Session Date and Time: October 23, 2017 from 8:00 AM to 5:30 PM

·        Authors: Christine I. Wooddell, et al.

Oct 10, 2017 10:45 AM EDT
Chardan Gene Therapy Conference